RENSSELAER, N.Y., May 19 (Bernama-GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in providing drug discovery animal model solutions, announces the successful implementation of its Rapid Restart™ program. Launched over a month ago, Taconic was the first animal model provider in the industry to provide researchers with a program specifically designed to aid laboratories transitioning back to increased productivity.
COVID-19 forced many institutions to discontinue critical research programs, and in some cases decrease their animal model use. As institutions consider ramping research back up, ensuring scientists have access to animal models is paramount. Taconic launched the Rapid Restart™ program to address this urgent and unique need. Rapid Restart™ is a planning service that provides customers with a unique blend of flexible scheduling and availability assurances to ensure they have what they need, when they need it.
